Download | < Back |
14 Mar 2017 | |
Clarification in response to queries received from analysts/investors regarding Mylan's announcement related to its global settlement and license agreement with Genentech and Roche on Herceptin | |
View all announcements for BIOCON LTD. | Source: BSE India |